US Stock MarketDetailed Quotes

HCWB HCW Biologics

Watchlist
  • 1.604
  • 0.0000.00%
Close Apr 23 14:59 ET
60.65MMarket Cap-2290P/E (TTM)

HCW Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
-57.72%2.84M
-1.31%1.32M
-52.84%853.1K
37.18%622.81K
-98.66%41.88K
6.72M
1.34M
1.81M
454K
3.12M
Operating revenue
-57.72%2.84M
-1.31%1.32M
-52.84%853.1K
37.18%622.81K
-98.66%41.88K
--6.72M
--1.34M
--1.81M
--454K
--3.12M
Cost of revenue
-44.84%2.28M
-0.17%1.07M
-53.13%678.33K
74.93%502.4K
-97.79%29.35K
4.14M
1.07M
1.45M
287.2K
1.33M
Gross profit
-78.33%560.36K
-5.84%252.65K
-51.69%174.78K
-27.81%120.41K
-99.30%12.53K
2.59M
268.3K
361.81K
166.8K
1.79M
Operating expense
48.75%26.28M
85.68%11.02M
19.88%5.25M
25.91%4.63M
46.39%5.37M
32.15%17.67M
90.70%5.94M
7.07%4.38M
33.69%3.68M
7.56%3.67M
Selling and administrative expenses
63.79%13.08M
29.24%3.56M
107.10%3.52M
74.42%2.95M
65.21%3.05M
60.55%7.99M
73.79%2.75M
25.05%1.7M
66.32%1.69M
81.64%1.84M
-General and administrative expense
63.79%13.08M
29.24%3.56M
107.10%3.52M
74.42%2.95M
65.21%3.05M
60.55%7.99M
73.79%2.75M
25.05%1.7M
66.32%1.69M
81.64%1.84M
Research and development costs
-17.80%7.68M
-27.09%2.14M
-37.05%1.67M
-17.93%1.62M
26.05%2.26M
14.25%9.34M
97.53%2.93M
-1.43%2.65M
17.73%1.97M
-23.18%1.79M
Depreciation amortization depletion
-21.18%266.76K
-69.17%78.31K
97.51%63.08K
282.51%64.8K
94.39%69.21K
54.92%338.46K
453.07%253.97K
-28.74%31.94K
-72.27%16.94K
-46.57%35.61K
-Depreciation and amortization
-21.18%266.76K
-69.17%78.31K
97.51%63.08K
282.51%64.8K
94.39%69.21K
54.92%338.46K
453.07%253.97K
-28.74%31.94K
-72.27%16.94K
-46.57%35.61K
Provision for doubtful accounts
--5.25M
----
----
----
----
--0
----
----
----
----
Operating profit
-70.55%-25.72M
-90.01%-10.77M
-26.33%-5.08M
-28.47%-4.51M
-185.01%-5.36M
-12.80%-15.08M
-82.08%-5.67M
1.77%-4.02M
-27.63%-3.51M
44.88%-1.88M
Net non-operating interest income expense
-123.47%-283.04K
101.51%1.42K
-196.77%-95.51K
-95.51K
-93.44K
-126.66K
83.32%-94.48K
-1,167.09%-32.18K
0
0
Non-operating interest expense
123.47%283.04K
-101.51%-1.42K
196.77%95.51K
--95.51K
--93.44K
--126.66K
--94.48K
--32.18K
--0
--0
Other net income (expense)
230.10%1.01M
-74.86%86.24K
70.55%234.75K
58,352.52%301.62K
317.31%383.32K
-39.70%304.74K
342.97K
137.65K
516
-176.4K
Other non- operating income (expenses)
230.10%1.01M
-74.86%86.24K
70.55%234.75K
58,352.52%301.62K
317.31%383.32K
-39.70%304.74K
--342.97K
--137.65K
--516
---176.4K
Income before tax
-67.74%-24.99M
-97.10%-10.68M
-26.17%-4.94M
-22.61%-4.3M
-146.48%-5.07M
-15.85%-14.9M
-70.75%-5.42M
4.41%-3.91M
-27.64%-3.51M
27.66%-2.06M
Income tax
Net income
-67.74%-24.99M
-97.10%-10.68M
-26.17%-4.94M
-22.61%-4.3M
-146.48%-5.07M
-15.85%-14.9M
-70.75%-5.42M
4.41%-3.91M
-27.64%-3.51M
27.66%-2.06M
Net income continuous Operations
-67.74%-24.99M
-97.10%-10.68M
-26.17%-4.94M
-22.61%-4.3M
-146.48%-5.07M
-15.85%-14.9M
-70.75%-5.42M
4.41%-3.91M
-27.64%-3.51M
27.66%-2.06M
Minority interest income
Net income attributable to the parent company
-67.74%-24.99M
-97.10%-10.68M
-26.17%-4.94M
-22.61%-4.3M
-146.48%-5.07M
-15.85%-14.9M
-70.75%-5.42M
4.41%-3.91M
-27.64%-3.51M
27.66%-2.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-67.74%-24.99M
-97.10%-10.68M
-26.17%-4.94M
-22.61%-4.3M
-146.48%-5.07M
-15.85%-14.9M
-70.75%-5.42M
4.41%-3.91M
-8.58%-3.51M
38.06%-2.06M
Basic earnings per share
-66.67%-0.7
-100.00%-0.3
-27.27%-0.14
-20.00%-0.12
-133.33%-0.14
39.13%-0.42
-69.07%-0.15
21.43%-0.11
-5.94%-0.1
38.13%-0.06
Diluted earnings per share
-66.67%-0.7
-100.00%-0.3
-27.27%-0.14
-20.00%-0.12
-133.33%-0.14
39.13%-0.42
-69.07%-0.15
21.43%-0.11
-5.94%-0.1
38.13%-0.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue -57.72%2.84M-1.31%1.32M-52.84%853.1K37.18%622.81K-98.66%41.88K6.72M1.34M1.81M454K3.12M
Operating revenue -57.72%2.84M-1.31%1.32M-52.84%853.1K37.18%622.81K-98.66%41.88K--6.72M--1.34M--1.81M--454K--3.12M
Cost of revenue -44.84%2.28M-0.17%1.07M-53.13%678.33K74.93%502.4K-97.79%29.35K4.14M1.07M1.45M287.2K1.33M
Gross profit -78.33%560.36K-5.84%252.65K-51.69%174.78K-27.81%120.41K-99.30%12.53K2.59M268.3K361.81K166.8K1.79M
Operating expense 48.75%26.28M85.68%11.02M19.88%5.25M25.91%4.63M46.39%5.37M32.15%17.67M90.70%5.94M7.07%4.38M33.69%3.68M7.56%3.67M
Selling and administrative expenses 63.79%13.08M29.24%3.56M107.10%3.52M74.42%2.95M65.21%3.05M60.55%7.99M73.79%2.75M25.05%1.7M66.32%1.69M81.64%1.84M
-General and administrative expense 63.79%13.08M29.24%3.56M107.10%3.52M74.42%2.95M65.21%3.05M60.55%7.99M73.79%2.75M25.05%1.7M66.32%1.69M81.64%1.84M
Research and development costs -17.80%7.68M-27.09%2.14M-37.05%1.67M-17.93%1.62M26.05%2.26M14.25%9.34M97.53%2.93M-1.43%2.65M17.73%1.97M-23.18%1.79M
Depreciation amortization depletion -21.18%266.76K-69.17%78.31K97.51%63.08K282.51%64.8K94.39%69.21K54.92%338.46K453.07%253.97K-28.74%31.94K-72.27%16.94K-46.57%35.61K
-Depreciation and amortization -21.18%266.76K-69.17%78.31K97.51%63.08K282.51%64.8K94.39%69.21K54.92%338.46K453.07%253.97K-28.74%31.94K-72.27%16.94K-46.57%35.61K
Provision for doubtful accounts --5.25M------------------0----------------
Operating profit -70.55%-25.72M-90.01%-10.77M-26.33%-5.08M-28.47%-4.51M-185.01%-5.36M-12.80%-15.08M-82.08%-5.67M1.77%-4.02M-27.63%-3.51M44.88%-1.88M
Net non-operating interest income expense -123.47%-283.04K101.51%1.42K-196.77%-95.51K-95.51K-93.44K-126.66K83.32%-94.48K-1,167.09%-32.18K00
Non-operating interest expense 123.47%283.04K-101.51%-1.42K196.77%95.51K--95.51K--93.44K--126.66K--94.48K--32.18K--0--0
Other net income (expense) 230.10%1.01M-74.86%86.24K70.55%234.75K58,352.52%301.62K317.31%383.32K-39.70%304.74K342.97K137.65K516-176.4K
Other non- operating income (expenses) 230.10%1.01M-74.86%86.24K70.55%234.75K58,352.52%301.62K317.31%383.32K-39.70%304.74K--342.97K--137.65K--516---176.4K
Income before tax -67.74%-24.99M-97.10%-10.68M-26.17%-4.94M-22.61%-4.3M-146.48%-5.07M-15.85%-14.9M-70.75%-5.42M4.41%-3.91M-27.64%-3.51M27.66%-2.06M
Income tax
Net income -67.74%-24.99M-97.10%-10.68M-26.17%-4.94M-22.61%-4.3M-146.48%-5.07M-15.85%-14.9M-70.75%-5.42M4.41%-3.91M-27.64%-3.51M27.66%-2.06M
Net income continuous Operations -67.74%-24.99M-97.10%-10.68M-26.17%-4.94M-22.61%-4.3M-146.48%-5.07M-15.85%-14.9M-70.75%-5.42M4.41%-3.91M-27.64%-3.51M27.66%-2.06M
Minority interest income
Net income attributable to the parent company -67.74%-24.99M-97.10%-10.68M-26.17%-4.94M-22.61%-4.3M-146.48%-5.07M-15.85%-14.9M-70.75%-5.42M4.41%-3.91M-27.64%-3.51M27.66%-2.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -67.74%-24.99M-97.10%-10.68M-26.17%-4.94M-22.61%-4.3M-146.48%-5.07M-15.85%-14.9M-70.75%-5.42M4.41%-3.91M-8.58%-3.51M38.06%-2.06M
Basic earnings per share -66.67%-0.7-100.00%-0.3-27.27%-0.14-20.00%-0.12-133.33%-0.1439.13%-0.42-69.07%-0.1521.43%-0.11-5.94%-0.138.13%-0.06
Diluted earnings per share -66.67%-0.7-100.00%-0.3-27.27%-0.14-20.00%-0.12-133.33%-0.1439.13%-0.42-69.07%-0.1521.43%-0.11-5.94%-0.138.13%-0.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg